Privacy Policy

At the Yorkshire Laser Centre, we’re committed to protecting and respecting your privacy.

This Policy explains when and why we collect personal information about people who visit our website, how we use it, the conditions under which we may disclose it to others and how we keep it secure.

We may change this Policy from time to time so please check this page occasionally to ensure that you’re happy with any changes. By using our website, you’re agreeing to be bound by this Policy.

Any questions regarding this Policy and our privacy practices should be sent by email to This email address is being protected from spambots. You need JavaScript enabled to view it. or by writing to the Yorkshire Laser Centre, Goole and District Hospital, Woodlands Avenue, Goole, East Yorkshire, DN14 6RX. Alternatively, you can telephone 01405 767451.

Who are we?

The Yorkshire Laser Centre is an independent company Limited by Guarantee (reg no:3547276). Its pioneering work and leadership within the British Medical Laser Association (BMLA) and the European Platform for Photodynamic Medicine (EPPM) has earned it a significant international reputation.

A growing number of associate Honorary Consultants work with the Centre to develop research and treatment within a wide range of medical disciplines such as dermatology, gynaecology, urology, orthopaedics, colo-rectal, oral, maxillo-facial and general surgery.

How do we collect information from you?

We obtain information about you when you use our website, for example, when you contact us about our services, make a donation or make an appointment.

What type of information is collected from you?

The personal information we collect might include your name, address, email address, IP address, and information regarding what pages are accessed and when. If you make a donation your information is collected as part of verification process for tax purposes.

How is your information used?

We may use your information to:

·         process a donation that you have made;

·         to carry out our obligations arising from any contracts entered into by you and us;

·         seek your views or comments on the services we provide;

·         notify you of changes to our services;

·         send you communications which you have requested and that may be of interest to you. These may include information about campaigns, appeals, other fundraising activities;

·         delivery of additional services.

We review our retention periods for personal information on a regular basis. We are legally required to hold some types of information to fulfil our statutory obligations (for example the collection of Gift Aid). We will hold your personal information on our systems for as long as is necessary for the relevant activity, or as long as is set out in any relevant contract you hold with us.

Who has access to your information?

We will not sell or rent your information to third parties.

We will not share your information with third parties for marketing purposes.

Third Party Service Providers working on our behalf: We may pass your information to our third party service providers, agents subcontractors and other associated organisations for the purposes of completing tasks and providing services to you on our behalf (for example to process donations). However, when we use third party service providers, we disclose only the personal information that is necessary to deliver the service and we have a contract in place that requires them to keep your information secure and not to use it for their own direct marketing purposes.

Please be reassured that we will never release your information to third parties beyond the Yorkshire Laser Centre Network for them to use for their own direct marketing purposes, unless you have requested us to do so, or we are required to do so by law, for example, by a court order or for the purposes of prevention of fraud or other crime.

How you can access and update your information

The accuracy of your information is important to us. We’re working on ways to make it easier for you to review and correct the information that we hold about you. In the meantime, if you change email address, or any of the other information we hold is inaccurate or out of date, please email us at: This email address is being protected from spambots. You need JavaScript enabled to view it. or by writing to Yorkshire Laser Centre, Goole and District Hospital, Woodlands Avenue, Goole, East Yorkshire, DN14 6RX. Alternatively, you can telephone 01405 767451.

You have the right to ask for a copy of the information The Yorkshire Laser Centre hold about you (we may charge £10 for information requests) to cover our costs in providing you with details of the information we hold about you.

Security precautions in place to protect the loss, misuse or alteration of your information

Non-sensitive details (your email address etc.) are transmitted normally over the Internet, and this can never be guaranteed to be 100% secure. As a result, while we strive to protect your personal information, we cannot guarantee the security of any information you transmit to us, and you do so at your own risk. Once we receive your information, we make our best effort to ensure its security on our systems. Where we have given (or where you have chosen) a password which enables you to access certain parts of our websites, you are responsible for keeping this password confidential. We ask you not to share your password with anyone.

Use of 'cookies'

Like many other websites, the the Yorkshire Laser Centre website uses cookies. 'Cookies' are small pieces of information sent by an organisation to your computer and stored on your hard drive to allow that website to recognise you when you visit. They collect statistical data about your browsing actions and patterns and do not identify you as an individual. For example, we use cookies to store your country preference. This helps us to improve our website and deliver a better more personalised service.

It is possible to switch off cookies by setting your browser preferences. For more information on how to switch off cookies on your computer, visit our full cookies policy. Turning cookies of may result in a loss of functionality when using our website.

Links to other websites

Our website may contain links to other websites run by other organisations. This privacy policy applies only to our website‚ so we encourage you to read the privacy statements on the other websites you visit. We cannot be responsible for the privacy policies and practices of other sites even if you access them using links from our website.

In addition, if you linked to our website from a third party site, we cannot be responsible for the privacy policies and practices of the owners and operators of that third party site and recommend that you check the policy of that third party site.

16 or Under

We are concerned to protect the privacy of children aged 16 or under. If you are aged 16 or under‚ please get your parent/guardian's permission beforehand whenever you provide us with personal information.

Transferring your information outside of Europe

As part of the services offered to you through this website, the information which you provide to us may be transferred to countries outside the European Union (“EU”). By way of example, this may happen if any of our servers are from time to time located in a country outside of the EU. These countries may not have similar data protection laws to the UK. By submitting your personal data, you’re agreeing to this transfer, storing or processing. If we transfer your information outside of the EU in this way, we will take steps to ensure that appropriate security measures are taken with the aim of ensuring that your privacy rights continue to be protected as outlined in this Policy.

Review of this Policy

We keep this Policy under regular review. This Policy was last updated in March 2018.

The Photodynamic Symposium at the Royal Society of Medicine, London, UK, organised by the RSM Professionals and the UK PDT Charitable Trust, has become an important fixture in the calendar of events at the RSM.

PDT is neither part of any of the Section of that illustrious establishment nor structurally is affiliated to one. However the symposium has been filling a gap within the education programme of the RSM.

Enormous thanks must go to all who presented at this year’s PDT symposium, helping to make it even more of a success than in previous years.

The programme served to demonstrate how the interaction between lab and clinical work can offer patients the newest, and ever improving, technologies and treatments. It truly underlined how inter-departmental co-operation works for the benefit of the patient.

Beginning with some ‘basics of PDT’, presenters from the UK and Switzerland demonstrated innovative aspects of mechanisms, dosimetry and enhancers. Following this were some exciting and thought provoking ideas about the use of PDT in micro-biology and the morning closed with work on the newest and the most unusual applications of PDT in Dermatology.

The afternoon brought us Imaging and Image Guided Surgery in oncology, followed by PDT in Lung Cancer and in Head and Neck.

The day rounded off with the Research in Progress; the PEARL trial and work on ABCG2 as a mechanism of resistance to PDT in 3D models of colo-rectal cancer.

The in-programme discussions were animated and far-reaching; the interest that had been aroused was palpable & All told, an educational and inspiring programme.

Sincere thanks to all concerned, not least our sponsors, but not forgetting the delegates who took the time to attend in the cause of furthering their continuing education.

 For those that weren't able to make the symposium, below are links to the videos taken on the day. 

Photodynamic Therapy Symposium | 27 November 2017 #1

Photodynamic Therapy Symposium | 27 November 2017 #2

Photodynamic Therapy Symposium | 27 November 2017 #3

Photodynamic Therapy Symposium | 27 November 2017 #4

Photodynamic Therapy Symposium | 27 November 2017 #5

Photodynamic Therapy Symposium | 27 November 2017 #6

Photodynamic Therapy Symposium | 27 November 2017 #7

Photodynamic Therapy Symposium | 27 November 2017 #8

Photodynamic Therapy Symposium | 27 November 2017 #9

Photodynamic Therapy Symposium | 27 November 2017 #10

Photodynamic Therapy Symposium | 27 November 2017 #11

 

Here at the Yorkshire Laser Centre we care about our patients and are aware that the knowledge of which options will help with your condition is key to decision making process and allowing you moving on with your life.

To help those that have been diagnosed with cancer we are happy to complete a thorough electronic review of your case notes to confirm if Photodynamic Therapy would help with your condition. As this is a premium service we do need to charge for the time this takes and the charge for this is £120.

If this is of interest to you please contact us and we can arrange for you to email your notes to us and supply the details for you to pay via Paypal.

Our work at the Yorkshire Laser Centre includes clinical trials of the effects of Photodynamic Therapy on different types of cancer. Some of the trials we have recently conducted include;

 

PDT Clinical studies

Indication

Title of study

 

No’s of patients recruited.

 

Lung Cancer

 

Study of the role of PDT in early central lung cancer: pilot study (K Moghissi YLC)

 

30

 

Photodetection

(for early lung cancer)

 

A pilot study of the accuracy of fluorescence bronchoscopy versus white light bronchoscopy in the detection of early bronchogenic cancer in high-risk individuals (K Moghissi YLC)

 

191

 

Oesophageal Cancer

 

Non-randomised comparison between endoscopic PDT and surgical resection in patients with early (stage I) oesophageal cancer (K Moghissi YLC)

 

80 (40 for each arm)

 

Oesophageal Cancer

 

Study to determine the place of endoscopic PDT within the range of treatment for oesophageal cancer. Matched pair subjects (K Moghissi YLC)

 

280 out of 1343 patients

 

 

Gynaecology

 

Study of the role of PDT in VIN: single or multiple PDT cycle (non-randomised prospective) – (C Gan Consultant Gynaecologist NLAG NHS Trust/YLC)

 

30 patients to date

 

Colo-rectal

 

Pilot study of the role of PDT in AIN in patients with or without HIV (G Duthie Dept of Academic Surgery/YLC)

 

26

 

Urology

 

Pilot study of the role of PDT in urothelial cancer ( L Coombs Consultant Urological Surgeon NLAG NHS Trust/YLC)

 

6 patients to date

Concerns around so-called ‘next generation’ PDT and sonodynamic therapy

Photodynamic therapy (PDT) is a treatment option for some types of cancer that involves administration of a drug that is activated by light, usually from a laser. This causes cell death. The underlying scientific principles and numerous clinical studies have been published in peer-reviewed literature1 2 3.  PDT can be curative. For example, in non-melanoma skin cancers, PDT has less morbidity than cryotherapy and avoids the need for skin grafts in surgical excision of large lesions. Often it is palliative where it can bring welcome symptomatic relief and precious extra months’ quality life to the patient.

PDT has several key attractions: there is minimal loss of normal tissue; PDT can be repeated in the same area as often as required; it can be used after conventional treatments have failed or as a stand-alone treatment in appropriate patients.

There are clinics providing what is sometimes called Next Generation PDT (NGPDT) or sonodynamic therapy (SDT). In general, the treatments provided do not have the necessary scientific rigour that is expected. Often the light is delivered externally and it is claimed that this reaches the tumour but light penetration to internal cancers is insufficient for effective PDT. A critical appraisal of a clinical application of SDT has been published4. This concludes that there is no convincing data that shows that treatment carried out as reported is effective in the treatment of primary tumour and multiple metastases. Without critical safety and efficacy information, it is unjustifiable to test unproven unconventional techniques and substances in patients, particularly those in terminal stages.

PDT can be used effectively in the treatment and care of appropriate cancer patients

The use of so-called NGPDT or SDT cannot be recommended.

 

Prof Harry Moseley, Hon President British Medical Laser Association; Prof Sam Eljamel, Clinical Director Scottish PDT Centre; Prof Keyvan Moghissi, Clinical Director Yorkshire Laser Centre

 

References

1              Moghissi K, Dixon K, Stringer M et al. Photofrin PDT for early stage oesophageal cancer: Long term results in 40 patients and literature review. Photodiagnosis and Photodynamic Therapy 2009; 6: 159-66.

2              Allison RR, Sibata C, Gay H. PDT for cancers of the head and neck. Photodiagnosis and Photodynamic Therapy 2009; 6: 1-2.

3              Morton CA, McKenna KE, Rhodes LE et al. Guidelines for topical photodynamic therapy: update. British Journal of Dermatology 2008; 159: 1245-66.

4              Huang Z, Moseley H, Bown S. Rationale of Combined PDT and SDT Modalities for Treating Cancer Patients in Terminal Stage: The Proper Use of Photosensitizer. Integrative Cancer Therapies 2010; 9: 317-9.